CHD1

Chr 5

chromodomain helicase DNA binding protein 1

Also known as: CHD-1, PILBOS

The CHD family of proteins is characterized by the presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. CHD genes alter gene expression possibly by modification of chromatin structure thus altering access of the transcriptional apparatus to its chromosomal DNA template. [provided by RefSeq, Jul 2008]

ResearchGenerating clinical summary…
LOFmechanismLOEUF 0.16
Clinical SummaryCHD1
🧬
Gene-Disease Validity (ClinGen)
complex neurodevelopmental disorder · ADLimited

Limited evidence — not for standalone diagnostic reporting

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
13 unique Pathogenic / Likely Pathogenic· 358 VUS of 485 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.16LOEUF
pLI 1.000
Z-score 8.28
OE 0.09 (0.060.16)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
4.21Z-score
OE missense 0.59 (0.550.64)
507 obs / 852.9 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.09 (0.060.16)
00.351.4
Missense OE?0.59 (0.550.64)
00.61.4
Synonymous OE?0.96
01.21.6
LoF obs/exp: 9 / 96.9Missense obs/exp: 507 / 852.9Syn Z: 0.53
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongCHD1-related neurodevelopment disorderLOFAD

This gene — mechanism propensity

DN
0.3196th %ile
GOF
0.2994th %ile
LOF
0.74top 10%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function, dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFprediction above median · 62% of P/LP variants are LoF · LOEUF 0.16
DN1 literature citation
GOF1 literature citation

Literature Evidence

DNOur results suggest that variants in CHD1 can lead to diverse phenotypic outcomes; however, the neurodevelopmental phenotype appears to be limited to patients with missense variants, which is compatible with a dominant negative mechanism of disease.1
GOFBy a series of domain-swapping and mutagenesis experiments, we identify Pro16 of E-cadherin as a residue critical for specificity: a Pro->Glu substitution in human E-cadherin totally abrogates interaction, whereas a Glu->Pro substitution in mouse E-cadherin results in a complete gain of function.2

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

485 submitted variants in ClinVar

Classification Summary

Pathogenic5
Likely Pathogenic8
VUS358
Likely Benign56
Benign10
Conflicting11
5
Pathogenic
8
Likely Pathogenic
358
VUS
56
Likely Benign
10
Benign
11
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
3
2
0
0
5
Likely Pathogenic
5
2
1
0
8
VUS
38
300
18
2
358
Likely Benign
2
14
3
37
56
Benign
0
6
2
2
10
Conflicting
11
Total483242441448

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

20 pathogenic / likely-pathogenic (of 29) ClinVar copy-number / structural variants overlap CHD1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

CHD1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →